TRCT
MCBK

Tower Research Capital (TRC)’s MADISON CNTY FINL INC COM STK (MD) MCBK Stock Holding History

Tower Research Capital (TRC)’s Portfolio MCBK Stock Details MCBK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-9,660
Closed -$199K – 5660
2015
Q3 		$199K Sell
9,660
-650
-6% -$13K 0.02% 293
2015
Q2 		$217K Buy
10,310
+9,981
+3,034% +$216K 0.02% 328
2015
Q1 		$7K Buy
329
+23
+8% +$475 ﹤0.01% 3117
2014
Q4 		$6K Buy
306
+293
+2,254% +$5.67K ﹤0.01% 2658
2014
Q3 		$0 Sell
13
-150
-92% -$2.79K ﹤0.01% 5309
2014
Q2 		$3K Buy
+163
New +$2.95K ﹤0.01% 3310
2014
Q1 		– Sell
-597
Closed -$11K – 5366
2013
Q4 		$11K Buy
+597
New +$10.5K ﹤0.01% 2941
2013
Q3 		– Sell
-850
Closed -$15K – 5138
2013
Q2 		$15K Buy
+850
New +$14.3K ﹤0.01% 2013

Other funds holding MCBK

TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
CCC
Chelsea Counsel Company Los Angeles, California $225M AUM 45.99% 1-Year Est. Return

Tower Research Capital (TRC)'s MCBK Position: Q4 2015 in Review

Tower Research Capital (TRC) sold out of MADISON CNTY FINL INC COM STK (MD) (MCBK) in Q4 2015, closing a stake of 9,660 shares — an estimated $199K sold.

Tower Research Capital (TRC) first reported a position in MCBK in Q2 2013 and held it in 8 quarters. The position peaked at $217K in Q2 2015. 2 funds tracked by Wall St. Rank hold MCBK as of Q4 2015.

  • Tower Research Capital (TRC) reported no remaining MADISON CNTY FINL INC COM STK (MD) position as of Q4 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 9,660 MADISON CNTY FINL INC COM STK (MD) shares in Q4 2015, an estimated $199K.
  • Tower Research Capital (TRC) first reported a position in MADISON CNTY FINL INC COM STK (MD) in Q2 2013 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s MADISON CNTY FINL INC COM STK (MD) position peaked at $217K in Q2 2015.
  • 2 funds tracked by Wall St. Rank held MADISON CNTY FINL INC COM STK (MD) as of Q4 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2015, filed 10 Feb 2016.